Biotech Startups

Life Science Nord is a cluster organization for the life sciences industry in Hamburg and Schleswig-Holstein, Germany, connecting around 300 members and stakeholders. It promotes innovation and the development of Northern Germany as a life science hub through networking and support services.

1 investor

LifeCell Diagnostics provides preventive health checkups and lab tests, including full-body checks, women's wellness packages, allergy panels, and organ-specific tests, with at-home sample collection and digital report delivery. It serves individuals across India through a network of NABL- and CAP-accredited labs.

1 investor

Lifeline manufactures a fully automated hematology analyzer for use in clinical settings including physician offices, clinics, urgent care centers, emergency rooms, hospitals, and research institutions.

1 investor

Life Magnetics develops carbon-coated magnetic bead kits for total RNA extraction and isolation, offering RNA purification with no DNase cleanup, room-temperature shipping, and compatibility with automated liquid and bead handling systems. The products serve research scientists and laboratories in the life sciences.

1 investor

A strategy consulting firm serving life sciences and biopharma organizations, offering corporate strategy, business development, commercial strategy, and operational transformation services. Its work spans deal advisory, product lifecycle planning, pricing and market access, and enterprise cost transformation.

1 investor

Life Science Angels provides an investment fellowship program for graduate students, postdocs, and early-career professionals to gain experience in life science entrepreneurship and investing. The program offers training in deal analysis, due diligence, investor relations, and mentorship from experienced entrepreneurs and investors.

1 investor

Lifespan Research Institute invests in biotechnology startups developing regenerative medicine and longevity therapies. The institute funds companies working on age-related disease treatment, including cellular senescence, tissue damage repair, and cancer therapeutics.

1 investor

Lift Biosciences develops Immunomodulatory Alpha Neutrophils (IMANs), off-the-shelf neutrophil-lineage cell therapies designed to kill tumor cells and restart anti-tumor immune responses in cancer patients. The company is preparing a first-in-human Phase 1 trial in patients with advanced cervical, head, and neck cancers.

1 investor

LigaChemBio is a biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) and small molecule therapeutics, with proprietary ADC technology and a drug development pipeline. The page shown is an investor disclosure section listing regulatory filings.

1 investor

Light Horse Therapeutics is a drug discovery company applying scientific expertise and innovation to advance healthcare through collaborative development. The company focuses on transforming drug discovery processes and bringing treatments to patients.

1 investor

Lighthouse Lab Services is a consulting and services company that helps clients start, run, and grow clinical laboratories, offering support across the clinical laboratory industry including staffing and operations. It serves healthcare and laboratory partners in the United States.

1 investor

Lightship provides clinical trial operations for biopharma companies, CROs, and academic institutions, offering site services, decentralized and hybrid trial models, patient recruitment, and mobile research units. Its research nurses conduct study visits in participants' homes, communities, or via mobile units to broaden trial access and improve enrollment and retention.

1 investor

Alpenglow Biosciences develops the Aurora 3D spatial biology platform, combining open-top light-sheet microscopy, volumetric data processing, and AI analysis to turn intact tissue into quantitative 3D data. It serves research, drug development, and diagnostic teams through outsourced 3D histology services and in-house imaging instruments, with applications in dermatology, immuno-oncology, and multi-field tissue analysis.

1 investor

Lightstone Ventures is a life science venture capital firm, founded in 2012, that invests in and helps build early- and growth-stage biotech and medtech companies developing new therapeutics and medical devices. It backs founders across areas such as oncology, immunology, CNS, cardiovascular, and ophthalmology, with offices in the U.S. and Ireland and activity in Singapore.

1 investor

Lila Sciences builds AI models and autonomous "AI Science Factory" lab instruments that run the scientific method on their own — generating hypotheses, designing and running experiments, and learning from results in real time. It offers this autonomous science platform to scientists and research organizations across multiple industries to speed up discovery and R&D.

1 investor

Lilium develops genetic medicines that selectively target pathogenic T cells in autoimmune diseases using engineered delivery vehicles for precision immune reprogramming. The company focuses on treating T-cell mediated autoimmune diseases and oncology indications that currently lack effective treatments.

1 investor

Lillianah Technologies develops low-cost biological wastewater treatment that cultivates diatoms in proprietary photobioreactors to reduce nitrogen, phosphorus, and organic material in municipal, agricultural, and food/industrial waste streams. It also pursues ocean-based carbon dioxide removal and provides monitoring, reporting, and verification using dissolved oxygen sensors and sediment measurement, with early project work focused on Nova Scotia and Louisiana.

1 investor

Limenbio develops gas-based preservation technology (branded HIPPER) for keeping viable cell grafts, tissues, and organs — including red blood cells, skin grafts, and hearts — using a modified gas atmosphere. Its methods target biomedical and transplantation applications such as extended organ and cell preservation prior to transplant.

1 investor

Link Cell Therapies is a biotechnology company developing logic-gate LINK CAR-T cell therapies aimed at treating solid and liquid tumors. It works in the cancer immunotherapy space and has a strategic collaboration with Johnson & Johnson.

1 investor

LinkoCare is a Swedish bioengineering company developing bio-engineered, natural-based corneal implants and inlays for sight restoration. Its products target patients with corneal blindness and low vision, offering full- and partial-thickness implants as alternatives to human donor corneas and synthetic solutions.

1 investor

Clinical-stage biotech company developing small molecule agents modulating cellular differentiation for cancer and pigmentation disorders.

1 investor

UIC is an organization that provides business coaching and advisory services to researchers and entrepreneurs in the life science sector, helping them navigate the journey from laboratory research to market commercialization.

1 investor

Lino Biotech develops the MACS Matchmaker, a label-free binding-analysis platform based on focal molography that measures antibody and drug-candidate kinetics directly in complex biological samples such as serum, lysate, and plasma. It serves biopharma and drug-discovery scientists with applications including polyreactivity screening, FcRn and Fc receptor profiling, plasma protein binding, DEL hit validation, and PROTAC ternary complex characterization.

1 investor

Lipidio Pharma is a drug development company that acquires molecules with unrealized therapeutic potential and advances them through preclinical and clinical development toward approval or exit. It is currently developing therapeutics for two indications, obesity and sebaceous hyperplasia.

1 investor